The 20 Best Adult Soft Tissue Sarcoma Doctors Near Me in Michigan, US

Scott Schuetze is an Oncologist and an Internal Medicine provider in Ann Arbor, Michigan. Dr. Schuetze is rated as an Elite provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Angiosarcoma, and Myxoid Liposarcoma.

Matthew Steensma is a Pediatrics specialist and a Surgical Oncologist in Grand Rapids, Michigan. Dr. Steensma has been practicing medicine for over 24 years and is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor, Neurofibromatosis, Adult Soft Tissue Sarcoma, and Hip Replacement. Dr. Steensma is currently accepting new patients.

Jared Knol is an Otolaryngologist and an Oncologist in Grand Rapids, Michigan. Dr. Knol has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Familial Prostate Cancer, Adult Soft Tissue Sarcoma, Laryngeal Cancer, and Rhabdoid Tumor Predisposition Syndrome. Dr. Knol is currently accepting new patients.

Patrick Grohar is a Pediatrics provider in Ann Arbor, Michigan. Dr. Grohar is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Ewing Sarcoma, Osteosarcoma, Adult Soft Tissue Sarcoma, and Rhabdoid Tumor.

Dr. Angeles is an Associate Professor with Tenure of Surgery, Associate Professor of Dermatology, and Faculty Member in the Cancer Biology PhD Program at the University of Michigan in the Division of Surgical Oncology. She earned her medical degree at Tufts University School of Medicine. She completed general surgery residency at New York Presbyterian-Weill Cornell Medical Center. While in residency she completed a two-year basic/translational science Surgical Oncology Research Fellowship at Memorial Sloan-Kettering Cancer Center (MSKCC) focusing on the molecular biology and novel therapeutics for sarcoma. After residency, Dr. Angeles returned to MSKCC and completed a clinical Complex Surgical Oncology Fellowship. Dr. Angeles is board-certified in both General Surgery and Complex General Surgical Oncology. She is the Director of the Regional Cancer Therapies Clinic at University of Michigan/Rogel Cancer Center. Dr. Angeles is a nationally recognized surgeon-scientist dedicated to advancing cancer care through innovative research and compassionate patient care. As the lead investigator for multiple clinical trials at the Rogel Cancer Center, she is at the forefront of developing new treatments for melanoma and sarcoma. Her laboratory studies the immune system’s role in fighting cancer, with a special focus on how resident memory T cells can help create long-lasting protection against tumors. By combining basic science and translational research, Dr. Angeles and her team are working to transform discoveries in the lab into effective new therapies for patients. Dr. Angeles’s research has been supported by the American Cancer Society, the Melanoma Research Alliance, the Society of Surgical Oncology, and the National Institutes of Health’s National Cancer Institute (NCI-NIH).Committed to excellence in both science and patient care, Dr. Angeles is a Fellow of the American College of Surgeons, a Fellow of the Society of Surgical Oncology, and an active member of professional societies including the American Society of Clinical Oncology (ASCO), the Society of Surgical Oncology (SSO), the Connective Tissue Oncology Society (CTOS), and the Society for Immunotherapy of Cancer (SITC). She also serves as Chair of the Society of Surgical Oncology's Research Committee, helping to shape the future of cancer research and treatment.Clinical Specialization:Dr. Angeles is a board-certified surgical oncologist whose clinical practice focuses on patients with soft tissue cancers including sarcoma, melanoma, and non-melanoma cutaneous malignancies. Dr. Angeles cares for patients in a robust multidisciplinary fashion and provides education and counseling to her patients in order to allow shared decision making for the surgical management of their disease. Dr. Angeles is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Liposarcoma, Adult Soft Tissue Sarcoma, Melanoma, Splenectomy, and Nephrectomy.

Rashmi Chugh is a Hematologist and an Oncologist in Ann Arbor, Michigan. Dr. Chugh is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Ganglioneuroblastoma, Rhabdomyosarcoma, Rhabdoid Tumor Predisposition Syndrome, and Rhabdoid Tumor.

Dr. Biermann serves as Director of the Musculoskeletal Oncology Program at the University of Michigan. Her clinical interests include malignant and benign tumors of soft tissue and bone, both primary and metastatic. Her practice includes both adults and children. Dr. Biermann chairs the Multidisciplinary Sarcoma Tumor Board, a collaborative cancer center group including medical and pediatric oncologists, pathologist, diagnostic radiologists, and radiation therapists. The Sarcoma clinic meets weekly. The University of Michigan Sarcoma team engages in patient care, clinical trials, and basic science research. In addition to her regional responsibilities, Dr. Biermann has been active in national committee and administrative work. She chairs the National Comprehensive Cancer Network (NCCN) Bone Tumors Panel. She is past president of the Musculoskeletal Tumor Society (MSTS). She is a member of the American Society of Clinical Oncology (ASCO). She sits on the Orthopaedic Research and Education Foundation (OREF) Grant Board. Her active research program has included more than 87 publications in the areas of musculoskeletal tumors and in the impact of the Internet on patient education. Dr. Biermann is the University of Michigan Medical Director for the Sarcoma Program and the Orthopaedic Surgery Residency Program Director. Dr. Biermann is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Ewing Sarcoma, Bone Tumor, Chondrosarcoma, Osteosarcoma, and Hip Replacement.

Dr. Geoffrey Siegel is a Michigan native who received his Medical Doctorate Degree at the Detroit Medical Center and his residency in Orthopaedic Surgery at Wayne State University. After finishing his fellowship in Orthopaedic Oncology at Vanderbilt University Medical Center in Nashville, Tennessee, he joined the Department of Orthopaedic Surgery at the University of Michigan as Clinical Assistant Professor.Dr. Siegel's clinical interests are in the treatment of benign and malignant disease, both metastatic as well as primary bone cancer in adults and children. His surgical interests include limb salvage and complex musculoskeletal reconstruction. He enjoys both resident and community physician education in the field of Musculoskeletal Oncology. Dr. Siegel is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Bone Tumor, Chondrosarcoma, Epithelioid Sarcoma, and Hip Replacement.

Dr. Lesly Dossett, MD, MPH, is the Maud T. Lane Research Professor for Cancer Quality Improvement and Chief of the Division of Surgical Oncology at the University of Michigan. Dr. Dossett earned her medical degree from Vanderbilt University School of Medicine in 2003, having attended on a United States Navy Health Professions Scholarship. She completed her general surgery residency at Vanderbilt University in 2010, which included a health services research fellowship and completion of an MPH. After residency, Dr. Dossett served on active duty with the United States Navy in several roles stateside and overseas, including completing two deployments supporting combat operations in Afghanistan. After leaving the Navy in 2014, Dr. Dossett completed a clinical fellowship in Complex General Surgical Oncology at Moffitt Cancer Center and joined the faculty of the University of Michigan in 2016.Dr. Dossett specializes in treating patients with melanoma, soft tissue sarcoma, and breast cancer. Her research leverages implementation science frameworks and behavioral strategies to improve healthcare value. As co-director of the Michigan Program for Value Enhancement (MPrOVE), she works to translate value-based research findings into practice at Michigan Medicine and then scale those strategies more broadly to hospitals and healthcare systems. She is a principal investigator for R01s funded by the National Cancer Institute (NCI) and the Agency for Healthcare Research and Quality (AHRQ). She serves as a mentor on several federally funded training grants and career development awards.Dr. Dossett is an active member of several national societies. She serves as an officer in the Association for Academic Surgeons (AAS) and in the executive leadership of the American College of Surgeons (ACS) Cancer Research Program (CRP) and the Surgical Outcomes Club.Clinical Specialization:Dr. Dossett’s clinical focus is on melanoma and non-melanoma skin cancers, sarcoma, and breast cancer. She has expertise in locally and regionally advanced melanoma, breast angiosarcoma, retroperitoneal and pelvic sarcoma, breast conservation therapy, and skin and nipple sparing mastectomy. Dr. Dossett is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Retroperitoneal Liposarcoma, Melanoma, Desmoplastic Small Round Cell Tumor, Mastectomy, and Lymphadenectomy.

Dr. Cuneo grew up in Northern California. He studied Biological and Environmental Engineering at Cornell University in Ithaca, NY. Dr. Cuneo received his Doctor of Medicine degree from Vanderbilt University School of Medicine in 2007 and completed an internship there in 2008. In 2008 he started his residency in Radiation Oncology at Duke University Medical Center. Dr. Cuneo has been an Assistant Professor in the Department of Radiation Oncology at the University of Michigan since 2012. Dr. Cuneo is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Anal Cancer, Pancreatic Cancer, Liposarcoma, Liver Cancer, and Pancreaticoduodenectomy.

Ajjai Alva is an Oncologist in Ann Arbor, Michigan. Dr. Alva is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Urothelial Cancer, Renal Cell Carcinoma (RCC), Bladder Cancer, Nephrectomy, and Lymphadenectomy.

Dr. Vaishampayan is the Director of the Phase I program at the Rogel Cancer Center, University of Michigan, Ann Arbor MI. Dr. Vaishampayan is a Professor of Internal Medicine and her research is primarily in translational drug development and early phase clinical trials in cancer with a focus on genitourinary malignancies. She has initiated, obtained funding for, and conducted and published many investigator initiated trials with embedded biomarkers and established multidisciplinary collaboration. She has served as site PI of the UO-1 Early Therapeutics Research Grant at Wayne State University. She was also the chair of the solid tumor division of oncology at WSU. She has completed formal leadership traning course and is Fellow of the Advisory Board (FAB). She is the appointed chair of the Advanced Renal committee of SWOG and a member of the Renal task force of the NCI. She is a board member of the Michigan Society of Hematology/Oncology (MSHO) and organizes annual board review course. Additionally, she has served as track leader for the ASCO education committee GU non prostate (Renal and bladder cancer) track. Dr. Vaishampayan attended Wayne State University for her residency and fellowship completion and attended medical school at Byramjee Jeejeebhoy in Pune, India and completed a higher secondary certificate in the field of science at Fergusson College in Pune, India.In her free time, Dr. Vaishampayan enjoys reading, dance, music and travel. Travel, reading (mysteries preferred), follows football. Dr. Vaishampayan is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Renal Cell Carcinoma (RCC), Prostate Cancer, Urothelial Cancer, Nephrectomy, and Orchiectomy.

David Michelin is an Oncologist in Traverse City, Michigan. Dr. Michelin has been practicing medicine for over 36 years and is rated as a Distinguished provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Endometrial Cancer, Vulvar Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, and Oophorectomy. Dr. Michelin is currently accepting new patients.

Emerson Lim is a Hematologist Oncology specialist and an Oncologist in Grand Rapids, Michigan. Dr. Lim has been practicing medicine for over 20 years and is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Prostate Cancer, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Clear Cell Sarcoma.

Laura Nadeau is a Hematologist and an Oncologist in Royal Oak, Michigan. Dr. Nadeau has been practicing medicine for over 27 years and is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Adult Immune Thrombocytopenia, Chronic Familial Neutropenia, and Bone Marrow Aspiration. Dr. Nadeau is currently accepting new patients.

Benjamin Gielda is a Radiation Oncologist in Saint Joseph, Michigan. Dr. Gielda has been practicing medicine for over 20 years and is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Posterior Fossa Tumor, Familial Prostate Cancer, and Gamma Knife Radiosurgery. Dr. Gielda is currently accepting new patients.

Nehal Lakhani is an Oncologist in Grand Rapids, Michigan. Dr. Lakhani has been practicing medicine for over 26 years and is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Lung Cancer, Adult Soft Tissue Sarcoma, Endometrial Cancer, and Pleuropulmonary Blastoma. Dr. Lakhani is currently accepting new patients.

Rohan Deraniyagala is a Radiation Oncologist in Royal Oak, Michigan. Dr. Deraniyagala has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Laryngeal Cancer, Nasopharyngeal Carcinoma, Lung Cancer, and Pleuropulmonary Blastoma. Dr. Deraniyagala is currently accepting new patients.

Ryan Nelson is a Urologist in Utica, Michigan. Dr. Nelson has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Bilateral Hydronephrosis, Hydronephrosis, Obstructive Uropathy, Nephrectomy, and Ureteroscopy. Dr. Nelson is currently accepting new patients.

Peter Chen is a Radiation Oncologist in Royal Oak, Michigan. Dr. Chen has been practicing medicine for over 48 years and is rated as an Advanced provider by MediFind in the treatment of Adult Soft Tissue Sarcoma. His top areas of expertise are Acoustic Neuroma, Intraductal Papilloma, Laryngeal Cancer, Schwannoma, and Gamma Knife Radiosurgery. Dr. Chen is currently accepting new patients.